GlassScriptPhysician profile
Barry Joel Weissman
NPI 1639103500
$540.50
in general payments reported to CMS, 2019-2025
10 companies · $95.23 in 2025
The $95.23 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.51 · 2020: $61.55 · 2021: $44.10 · 2022: $37.93 · 2023: $166 · 2024: $108 · 2025: $95.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $110.09 | 2019-2024 | |
| Glaxosmithkline, LLC. | $106.65 | 2022-2025 | Bexsero, Rotarix, Penmenvy |
| Merck Sharp & Dohme LLC | $94.17 | 2023-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sobi, INC | $54.85 | 2019-2023 | |
| Alk-Abello, INC | $44.52 | 2025 | Neffy |
| Sanofi Pasteur INC. | $33.83 | 2023-2025 | |
| Cumberland Pharmaceuticals, INC. | $30.08 | 2023 | Kristalose |
| Cranial Technologies, INC | $26.32 | 2020-2023 | Doc Band |
| Emmaus Medical, INC. | $22.93 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Weissman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.